Epibrassinolide (24-Epibrassinolide; B1105; BP55) is a naturally occurring plant growth hormone which shows great potential to alleviate heavy metals and pesticide stress in plants. Epibrassinolide has the potential to induce apoptosis in a variety of cancer cells without impairing the growth of normal cells.
Physicochemical Properties
Molecular Formula | C₂₈H₄₈O₆ |
Molecular Weight | 480.68 |
Exact Mass | 480.345 |
CAS # | 78821-43-9 |
Related CAS # | Brassinolide;72962-43-7 |
PubChem CID | 443055 |
Appearance | White to off-white solid |
Density | 1.1±0.1 g/cm3 |
Boiling Point | 633.7±55.0 °C at 760 mmHg |
Melting Point | 256°C |
Flash Point | 202.3±25.0 °C |
Vapour Pressure | 0.0±4.2 mmHg at 25°C |
Index of Refraction | 1.536 |
LogP | 3.12 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Heavy Atom Count | 34 |
Complexity | 755 |
Defined Atom Stereocenter Count | 13 |
SMILES | C[C@@]12[C@@H]([C@H](C)[C@@H](O)[C@H](O)[C@H](C)C(C)C)CC[C@H]1[C@@H]1COC(=O)[C@H]3C[C@@H]([C@@H](C[C@]3(C)[C@H]1CC2)O)O |
InChi Key | IXVMHGVQKLDRKH-QHBHMFGVSA-N |
InChi Code | InChI=1S/C28H48O6/c1-14(2)15(3)24(31)25(32)16(4)18-7-8-19-17-13-34-26(33)21-11-22(29)23(30)12-28(21,6)20(17)9-10-27(18,19)5/h14-25,29-32H,7-13H2,1-6H3/t15-,16+,17+,18-,19+,20+,21-,22+,23-,24-,25-,27-,28-/m1/s1 |
Chemical Name | (1S,2R,4R,5S,7S,11S,12S,15R,16S)-15-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-8-one |
Synonyms | 24-Epibrassinolide; B1105; BP55;B 1105; BP 55; B-1105; BP-55 |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | Plant growth regulator; Apoptosis inducer |
ln Vitro | Epibrassinolide (EBR) is a bioactive molecule from the brassinosteroid family of plant growth regulators. Cells were treated with epibrassinolide at varying concentrations (0-100 μM) for 24 or 48 hours, and cell viability was assessed by MTT. In contrast to untreated samples in LNCaP and DU145 gun molds, epibrassinosteroid caused cell viability death in a dose and time-dependent manner. Increasing epibrassinolide concentrations caused higher cell viability loss in LNCaP cells than DU145 cells, showing that epibrassinolide has a greater influence on androgenic cell proliferation and cell death than androgenic products. Further trials used 25 μM epibrassinolide, which produced the most cytotoxic effects on both cell types. Calculate cell data for 96 hours to see how Epibrassinolide therapy affects cell proliferation. LNCaP cells showed a higher and earlier suppression of cell growth compared to DU145 cells [1]. |
Cell Assay | The PNT1a normal prostate epithelial cell line is utilized. Cells are grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 10,000 U penicillin/mL, and 10 mg streptomycin/mL. (HERA cell 150) Cells are cultured at 37°C in an incubator with humidified 5% CO2. The desired drug concentrations are applied after cells have been seeded overnight. In 96-well plates, cells are seeded at a density of 1×104 per well and exposed to various Epibrassinolide concentrations for 24 and 48 hours. Each well receives 10 μL of MTT dye (5 mg/mL), and cells are incubated at 37°C for 4 hours. In 200 L DMSO, the formed formazan crystals are solubilized. At 570 nm, spectrophotometric measurements of the solubilized formazan's density are made[1]. |
References |
[1]. Role of 24-epibrassinolide (EBL) in mediating heavy metal and pesticide induced oxidative stress in plants: A review. Ecotoxicol Environ Saf. 2018 Jan;147:935-944. [2]. Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines.Amino Acids. 2014 Mar;46(3):553-64. |
Additional Infomation |
24-epi-brassinolide is a 2alpha-hydroxy steroid, a 3alpha-hydroxy steroid, a 22-hydroxy steroid, a 23-hydroxy steroid and a brassinosteroid. 24-epi-Brassinolide has been reported in Vicia faba, Gypsophila perfoliata, and other organisms with data available. See also: Brassinolide (annotation moved to). |
Solubility Data
Solubility (In Vitro) |
DMSO: 96~100 mg/mL (199.7~208.0 mM) Ethanol: ~16 mg/mL (~33.3 mM) |
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples. Injection Formulations (e.g. IP/IV/IM/SC) Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] *Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline) Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline) Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline) Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil) Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). Oral Formulation 3: Dissolved in PEG400 Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose Oral Formulation 6: Mixing with food powders Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.0804 mL | 10.4019 mL | 20.8039 mL | |
5 mM | 0.4161 mL | 2.0804 mL | 4.1608 mL | |
10 mM | 0.2080 mL | 1.0402 mL | 2.0804 mL |